Kidney Function Tests Market Scope
The global Kidney Function Tests market is expected to boost in the forecasted period due to the increasing number of Kidneyrelated diseases across the world. Kidneys are among the most vital organs of the human body. kidney function tests are simple blood and urine tests that can help identify problems with kidneys. Additionally, other complications including high blood pressure are contributing to the rising incidence rate and prevalence of chronic kidney disease worldwide. Demand for kidney function tests is mainly triggered by the presence of a large patient population suffering from renal disorders."In 2013, 88.2 percent of all incident cases began renal replacement therapy with hemodialysis, 9.0 percent started with peritoneal dialysis, and 2.6 percent received a preemptive kidney transplant."
The market study is being classified by Type (Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests] and Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests]) and major geographies with country level break-up. According to AMA, the Global Kidney Function Tests market is expected to see growth rate of 7.3%
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Kidney Function Tests market throughout the predicted period.
Abbott (United States), Nova Biomedical (United States), Siemens (Germany), URIT Medical (China), Sysmex (Japan), Roche (Switzerland), Beckman Coulter (United States), ARKRAY (Japan), OPTI Medical (United States) and ACON Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are 77 Elektronika (Hungary) and Randox Laboratories (United Kingdom).
AdvanceMarketAnalytics has segmented the market of Global Kidney Function Tests market by Type, Application and Region.
On the basis of geography, the market of Kidney Function Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
On 23rd October 2018, Siemens Healthineers has teamed up with Israeli start-up Healthy.io to allow patients to test their urine at home by using a smartphone camera that scans a dipstick and sends the results to their doctor.
- Growing Demand for a High Incidence Rate of Renal Fibrosis
- High Demand for Cost-Effectiveness Of Dipstick Testing
- The Rising Prevalence Of Chronic Kidney Diseases
- The Increasing Number of Individuals Suffering from Diabetes
- Increasing Healthcare Expenditure in the Developing Countries
- Growing Initiatives by the Government for the Awareness and Treatment of Kidney Diseases
- The Growing Concern Related to Stringent Regulatory Approvals
Key Target AudienceKidney Function Test Providers, Diagnostic Laboratories, Government Regulatory Bodies, Private Research Organizations, Government Research Organizations and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase